Kollintzas Dean G 4

What Happened
Dean G. Kollintzas, a director of GeoVax Labs, Inc. (GOVX), was reported to have received a derivative award of 6,000 shares on June 17, 2026. The filing lists the acquisition price as $0.00 (transaction code A — grant/award), indicating an awarded grant or similar equity compensation rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-17; Form 4 filed: 2026-06-22 (filing appears late — more than two business days after the transaction).
• Transaction type/code: A = Award/Grant (derivative acquisition).
• Shares acquired: 6,000; Reported acquisition price/value: $0.00 (derivative award).
• Shares owned after transaction: Not specified in the filing.
• No sale or cash exercise reported; no 10b5-1 plan, tax withholding, or other footnotes noted in the summary provided.

Context
An award/grant (derivative) typically represents restricted stock, RSUs, or another form of equity compensation that may vest over time; such grants do not necessarily reflect an immediate buy/sell decision. The late filing is an administrative detail — it does not change the underlying award but delays public disclosure.